✳flâneur — a map of the web's best reading
Protein degradation reaches further out
nature.com · 474 words · saved by 1 readers
Discover the world’s best science and medicine | Nature.com
Email Bluesky Facebook LinkedIn Reddit Whatsapp X Access through your institution Buy or subscribe Although the development of efficient and selective small-molecule inhibitors and monoclonal antibodies has improved over the years, ‘undruggable’ proteins can still elude these established drug modalities. Targeted protein degradation with proteolysis-targeting chimaeras (PROTACs) has emerged as an attractive route to target these difficult proteins. However, this approach is limited to proteins that have intracellular domains, meaning that ~40% of the proteome is out of scope. Now, Bertozzi and
Explore this link on the map →saved by
related reading
- Lysosome-targeting chimeras evolve | Nature Chemical Biologynature.com
- Lysosome-targeting chimaeras for degradation of extracellular proteins | Naturenature.com
- Frontiers | Therapeutic Antibodies against Intracellular Tumor Antigensfrontiersin.org
- Gap Mapgap-map.org
- Checking your browser - reCAPTCHApmc.ncbi.nlm.nih.gov
- Engineering Plastic-Degrading Enzymes and PCSK9 Binders with Protein AI Toolsblog.latch.bio
- Has pancreatic cancer met its match?worksinprogress.co
- Manifold Bio | Tissue-targeted medicines, designed in vivomanifold.bio
- Applications of Enzyme Technology to Enhance Transition to Plant Proteins: A Review - PMCpmc.ncbi.nlm.nih.gov
- Checking your browser - reCAPTCHAncbi.nlm.nih.gov
- Ludovico Comitoludocomito.dev
- Proximity labeling in mammalian cells with TurboID and split-TurboID | Nature Protocolsnature.com